Paragon Care has the GF Score of 56, which implies that the company
might have
Poor future performance potential.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Paragon Care
might have
Poor future performance potential.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Paragon Care (FRA:PXS) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Paragon Care GF Score Related Terms
FRA:PXS vs MCK, CAH, COR: GF Score Comparison
For the Medical Distribution subindustry, Paragon Care's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paragon Care GF Score vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Paragon Care's GF Score distribution charts can be found below:
* The bar in red indicates where Paragon Care's GF Score falls into.
Paragon Care (FRA:PXS) has a GF Score of 56 as of Jul. 09, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Paragon Care and its competitors. This is near median its historical median of 54.00. Over the past decade, Paragon Care's GF Score has ranged from 25.00 to 75.00.
Is Paragon Care's GF Score too high?
Paragon Care's current GF Score of 56 is near median its 10-year median of 54.00. Over the past 10 years, this metric has ranged from a low of 25.00 to a high of 75.00. Overall, Paragon Care has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Paragon Care's GF Score compare to MCK and CAH?
Paragon Care's GF Score of 56 can be compared against companies in the Medical Distribution industry. Historically, Paragon Care's own GF Score has ranged from 25.00 to 75.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Distribution company?
A good GF Score depends on the Medical Distribution industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Paragon Care and its competitors. Paragon Care's current GF Score is 56, which is near median its own 10-year median of 54.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paragon Care stock overvalued right now?
Based on GuruFocus' analysis, Paragon Care (FRA:PXS) is currently considered Possible Value Trap. The stock's GF Value™ is €0.23, compared to a current price of €0.08 — trading 67% below its estimated fair value. The current GF Score is 56, which is near median its 10-year median of 54.00. Paragon Care's overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Paragon Care (FRA:PXS), the current GF Score is 56 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paragon Care (FRA:PXS) Overvalued in 2026?
Based on GuruFocus' analysis, Paragon Care stock appears to be undervalued.
The current stock price of €0.08 is trading 67% below its estimated GF Value™ of €0.23.
GuruFocus considers Paragon Care to be Possible Value Trap.
Key valuation signals for FRA:PXS:
GF Score: 56 (near median its 10-year median of 54.00)
GF Value™: €0.23 vs. price of €0.08 (67% below fair value)
No single metric tells the full story. See the FRA:PXS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paragon Care Ltd is a medical device company. The company provides medical equipment, devices, and consumables medical products to the healthcare market. The company provides solutions to various healthcare markets, aged care, and veterinary markets. The group is organized into two operating segments: ParagonCare and CH2 Holdings and the majority of its revenues are generated from the CH2 Holdings segment engaged in the distribution of pharmaceuticals, medical consumables, nutritional, and over-the-counter products to the healthcare market.
56GF Score
Get the complete analysis for FRA:PXS
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PXS has been successfully added to your 